1. On exposure of synovial fluid to superoxide and hydrogen peroxide, generated enzymically or by activated polymorphonuclear leucocytes, hyaluronic acid is depolymerized and the fluid loses its lubricating properties. The ability of synovial fluid from rheumatoid patients to scavenge superoxide and hydrogen peroxide was therefore examined.
Introduction
Oxygen-derived species such as superoxide (O,*-) and hydrogen peroxide (H,O,) In the present paper we report an examination of the ability of synovial fluid from a number of
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rheumatoid patients to scavenge 02*-and H,O,, including measurements of ascorbic acid concentrations in both serum and synovial fluid.
Materials and methods

Enzyme assays
Superoxide dismutase was assayed by its ability to inhibit the production of formazan from nitro-blue tetrazolium with a mixture of xanthine and xanthine oxidase to generate 02'-. Assays were carried out at both pH 10-2 [21] and 7.8 D I . 
Determination of ascorbic acid
Ascorbate plus dehydroascorbate was determined with the dinitrophenylhydrazine reagent as described previously [241, except that the colour reagent contained 0.6% CuSO, to oxidize ascorbate, rather than charcoal. The method was calibrated with freshly prepared ascorbate solutions.
Patients
The synovial fluid used in these experiments was a small fraction of samples drawn from patients for authentic medical purposes. All the patients fulfilled the criteria of the American Rheumatism Association for classical or definite rheumatoid arthritis. Bloodstained fluids were not used in these experiments.
Results
Samples of synovial fluid from the knee joints of a range of rheumatoid patients were centrifuged to remove cells and then assayed for superoxide dismutase and catalase activities by sensitive spectrophotometric methods (see the Materials and methods section). Fig. 1 shows a typical result for superoxide dismutase. No superoxide dismutase activity could be detected in fluid from the eight patients tested. Addition of authentic superoxide dismutase to the synovial fluid before assay resulted in the expected enzyme activity, which shows that the fluids did not contain any inhibitor of this enzyme (Fig. 1) .
The assay procedure used would detect any protein that reacted with 02*-. Hence the ability of any caeruloplasmin present in the fluid to scavenge 02.-must have been negligible. Results of the catalase assays are summarized in Table 1 . Again, addition of authentic catalase to the samples before assay resulted in the expected enzyme activity, showing that the fluids did not contain any catalase inhibitor.
The values in Table 1 show that the catalase activity of fluids varied from patient to patient, but was generally low or absent. For comparison, pure human catalase has a specific activity of approximately 30 000 units/mg of protein under the same assay conditions.
The samples of synovial fluid were also assayed for their total ascorbate content (i.e. reduced ascorbate plus dehydroascorbate). Indomethacin plus Ibuprofen
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Naproxen plus o-penicillamine 55 TABLE 2. Ascorbate concentrations in the plasma and synovialfluid of rheumatoid patients The method used measures both ascorbate and dehydroascorbate. Extra ascorbic acid added to the fluids was detected quantitatively in the subsequent assay, which indicates that the other components of synovial .fluid do not interfere with the assay procedure. Ascorbic acid was not lost at a significant rate if fluids were stored frozen at -2OoC, although most determinations were performed on freshly-drawn samples.
Sample
Plasma ascorbate Synovial fluid ascorbate no.
(Pan (Porn   1  33  35  2  41  40  3  22  22  4  30  36  5  60  49  6  14  14  7  31  38  8  15 19 (Right knee) Plasma samples from the same patients were assayed simultaneously. Results are summarized in Table 2 . It may be seen that synovial fluid and plasma had similar total ascorbate concentrations in most cases and that in all cases the concentrations were low (normal serum ascorbate is in the range of 0.040-0-141 mmol/l) [261.
Discussion
The results in this paper have shown that, unlike bovine synovial fluid [ 121, Table 2 represent reduced ascorbate plus dehydroascorbate, and only the former reacts with 0;-1161, the effective scavenging ability might well be even less than that implied by Table 2 .
It follows that synovial fluid from rheumatoid patients has no protection against O,*-and H,O, generated by active leucocytes. Since rheumatoid fluid has a high iron content [8], an interaction of 02'-and H,O, to generate OH' radicals seems almost certain to occur in vivo. This perhaps accounts for the extensive loss of viscosity of synovial fluid that is seen in inflammatory joint disease 191.
In the rheumatoid patients studied serum and synovial ascorbate concentrations were very similar. It seems likely, therefore, that a similar situation exists in normal humans, in which case synovial fluid ascorbate concentrations will be higher and will exert a greater protection against any O,*-radical generated.
